These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 24806303

  • 1. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
    Gessi M, Moneim YA, Hammes J, Goschzik T, Scholz M, Denkhaus D, Waha A, Pietsch T.
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
    [Abstract] [Full Text] [Related]

  • 2. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
    Gessi M, Waha A, Setty P, Waha A, Pietsch T.
    Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
    [Abstract] [Full Text] [Related]

  • 3. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
    Gessi M, Lambert SR, Lauriola L, Waha A, Collins VP, Pietsch T.
    J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
    [Abstract] [Full Text] [Related]

  • 4. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP, Scapulatempo-Neto C, Carloni AC, Paulino A, Sheren J, Aisner DL, Musselwhite E, Clara C, Machado HR, Oliveira RS, Neder L, Varella-Garcia M, Reis RM.
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG, Gupta R, Doo P, Lee JC, Cadwell CR, Ramani B, Hofmann JW, Sloan EA, Kleinschmidt-DeMasters BK, Lee HS, Wood MD, Grafe M, Born D, Vogel H, Salamat S, Puccetti D, Scharnhorst D, Samuel D, Cooney T, Cham E, Jin LW, Khatib Z, Maher O, Chamyan G, Brathwaite C, Bannykh S, Mueller S, Kline CN, Banerjee A, Reddy A, Taylor JW, Clarke JL, Oberheim Bush NA, Butowski N, Gupta N, Auguste KI, Sun PP, Roland JL, Raffel C, Aghi MK, Theodosopoulos P, Chang E, Hervey-Jumper S, Phillips JJ, Pekmezci M, Bollen AW, Tihan T, Chang S, Berger MS, Perry A, Solomon DA.
    Acta Neuropathol Commun; 2020 Aug 28; 8(1):151. PubMed ID: 32859279
    [Abstract] [Full Text] [Related]

  • 6. Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.
    Solis OE, Mehta RI, Lai A, Mehta RI, Farchoukh LO, Green RM, Cheng JC, Natarajan S, Vinters HV, Cloughesy T, Yong WH.
    J Neurooncol; 2011 May 28; 102(3):477-84. PubMed ID: 20872044
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle.
    Zhang J, Babu R, McLendon RE, Friedman AH, Adamson C.
    J Clin Neurosci; 2013 Mar 28; 20(3):335-41. PubMed ID: 23375398
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
    Kitamura Y, Komori T, Shibuya M, Ohara K, Saito Y, Hayashi S, Sasaki A, Nakagawa E, Tomio R, Kakita A, Nakatsukasa M, Yoshida K, Sasaki H.
    Brain Pathol; 2018 Jan 28; 28(1):87-93. PubMed ID: 27893178
    [Abstract] [Full Text] [Related]

  • 9. Rosette-forming glioneuronal tumor of the fourth ventricle.
    Preusser M, Dietrich W, Czech T, Prayer D, Budka H, Hainfellner JA.
    Acta Neuropathol; 2003 Nov 28; 106(5):506-8. PubMed ID: 12915951
    [Abstract] [Full Text] [Related]

  • 10. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
    Sievers P, Appay R, Schrimpf D, Stichel D, Reuss DE, Wefers AK, Reinhardt A, Coras R, Ruf VC, Schmid S, de Stricker K, Boldt HB, Kristensen BW, Petersen JK, Ulhøi BP, Gardberg M, Aronica E, Hasselblatt M, Brück W, Bielle F, Mokhtari K, Lhermitte B, Wick W, Herold-Mende C, Hänggi D, Brandner S, Giangaspero F, Capper D, Rushing E, Wesseling P, Pfister SM, Figarella-Branger D, von Deimling A, Sahm F, Jones DTW.
    Acta Neuropathol; 2019 Sep 28; 138(3):497-504. PubMed ID: 31250151
    [Abstract] [Full Text] [Related]

  • 11. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, Gupta P, Wang S, Lee RP, Brat D, Peter Collins V, Dahiya S, George D, Konomos W, Kurian KM, McFadden K, Serafini LN, Nickols H, Perry A, Shurtleff S, Gajjar A, Boop FA, Klimo PD, Mardis ER, Wilson RK, Baker SJ, Zhang J, Wu G, Downing JR, Tatevossian RG, Ellison DW.
    Acta Neuropathol; 2016 Jun 28; 131(6):833-45. PubMed ID: 26810070
    [Abstract] [Full Text] [Related]

  • 12. Rosette-forming glioneuronal tumor of the fourth ventricle with bilateral olivary degeneration.
    Fushimi Y, Miyasaki A, Taki H, Aoyama K, Hirato J, Kanagaki M, Togashi K.
    Jpn J Radiol; 2011 Jul 28; 29(6):445-8. PubMed ID: 21786101
    [Abstract] [Full Text] [Related]

  • 13. Imaging features of rosette-forming glioneuronal tumours (RGNTs): A Series of seven cases.
    Medhi G, Prasad C, Saini J, Pendharkar H, Bhat MD, Pandey P, Muthane Y.
    Eur Radiol; 2016 Jan 28; 26(1):262-70. PubMed ID: 26017735
    [Abstract] [Full Text] [Related]

  • 14. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    Ishi Y, Yamaguchi S, Hatanaka KC, Okamoto M, Motegi H, Kobayashi H, Terasaka S, Houkin K.
    J Neurosurg; 2021 Mar 01; 134(3):733-741. PubMed ID: 32059187
    [Abstract] [Full Text] [Related]

  • 15. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
    Yamada S, Nobusawa S, Yamazaki T, Teranishi T, Watanabe S, Murayama K, Ohba S, Okabe A, Sakurai K, Urano M, Tsukamoto T, Yokoo H, Hirose Y, Abe M.
    Pathol Int; 2019 Jun 01; 69(6):372-377. PubMed ID: 31218776
    [Abstract] [Full Text] [Related]

  • 16. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report.
    Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GN.
    Clin Neuropathol; 2014 Jun 01; 33(6):407-11. PubMed ID: 24986181
    [Abstract] [Full Text] [Related]

  • 17. Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature.
    Hsu C, Kwan G, Lau Q, Bhuta S.
    Br J Neurosurg; 2012 Oct 01; 26(5):668-73. PubMed ID: 22512825
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rosette-forming glioneuronal tumor of the fourth ventricle: report of two cases with a differential diagnostic overview.
    Vajtai I, Arnold M, Kappeler A, Jeless O, Lukes A, Mariani L, Paulus W.
    Pathol Res Pract; 2007 Oct 01; 203(8):613-9. PubMed ID: 17651910
    [Abstract] [Full Text] [Related]

  • 20. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F, Barets D, Colin C, Bouvier C, Padovani L, Nanni-Metellus I, Ouafik L, Scavarda D, Korshunov A, Jones DT, Figarella-Branger D.
    Oncotarget; 2017 Jan 10; 8(2):2104-2113. PubMed ID: 27791984
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.